本文采用泰必利,多虑平联合治疗24例三叉神经痛,并用卡马西平治疗24例作对照结果表明,前者效优为75％(18例),显效25％(6例),后者效优为66.3％(16例),显效25％(6例)无效8.3％(2例),两组疗效有显著性差异(P<0.005),证明泰必利100—200ng多虑平25—50mg每日三次联用明显优于卡马西平0.1—0.2每日三次,泰必利,多虑平治疗,治愈时间平均为7.1天,副反应小,而卡马西平治愈时间平均为9.7天,(二组有显著性差异t=2.25,P<0.005),且对肝功能,脑电图,血液均有明显的影响。临床医师可试用本疗法。 24 cases of trigeminal neuralgia were treated with tiapride and doxepin, and 24 cases were treated with carbamazepine. The results showed that the former was 75% effective (18 cases) and the latter 25 cases (6 cases), the latter The efficacy was 66.3% (16 cases), effective 25% (6 cases) and ineffective 8.3% (2 cases). There was significant difference between the two groups (P <0.005) 50mg three times a day was significantly better than carbamazepine 0.1-0.2 three times a day, tiapride, doxepin treatment, the average healing time was 7.1 days, the side effects of small, while the average time of carbamazepine was 9.7 days, (Two groups have significant difference t = 2.25, P <0.005), and have obvious effect on liver function, electroencephalogram and blood. Clinicians can try this therapy.